• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthoquinones
• Naphthoquinones
• Solvents and Organic Chemicals Organic Compounds Heterocyclic Compounds

Research Brief on 1,4-Naphthalenedione, 2-hydroxy-3,6-dimethyl- (9CI) (CAS: 33253-99-5)

The compound 1,4-Naphthalenedione, 2-hydroxy-3,6-dimethyl- (9CI), with the CAS number 33253-99-5, has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This naphthoquinone derivative is being explored for its potential biological activities, including its role as an intermediate in the synthesis of pharmacologically active molecules and its intrinsic properties that may contribute to therapeutic applications.

Recent studies have focused on the synthesis and characterization of this compound, leveraging advanced spectroscopic techniques such as NMR and mass spectrometry to confirm its structure and purity. Researchers have also investigated its reactivity under various conditions, providing insights into its potential utility in organic synthesis and drug development. The compound's unique structural features, including the hydroxyl and methyl substituents, are believed to influence its electronic properties and biological interactions.

In the context of biomedical applications, preliminary studies suggest that 1,4-Naphthalenedione, 2-hydroxy-3,6-dimethyl- (9CI) may exhibit antioxidant and cytotoxic properties. These findings are particularly relevant in the search for novel anticancer agents, as naphthoquinones are known to interfere with cellular redox processes and induce apoptosis in cancer cells. However, further in vitro and in vivo studies are required to elucidate its mechanisms of action and evaluate its therapeutic potential.

Additionally, the compound's role as a building block in the synthesis of more complex molecules has been explored. Its ability to undergo various chemical transformations, such as Michael additions and cycloadditions, makes it a valuable intermediate in the development of new chemical entities with potential pharmacological activities. Researchers are also investigating its stability and solubility profiles to optimize its use in drug formulation.

Despite these promising findings, challenges remain in the development of 1,4-Naphthalenedione, 2-hydroxy-3,6-dimethyl- (9CI) for clinical applications. Issues such as bioavailability, toxicity, and scalability of synthesis need to be addressed. Collaborative efforts between chemists, biologists, and pharmacologists are essential to overcome these hurdles and advance the compound's potential from bench to bedside.

In conclusion, 1,4-Naphthalenedione, 2-hydroxy-3,6-dimethyl- (9CI) represents a compound of significant interest in chemical biology and pharmaceutical research. Its unique structural and functional properties offer opportunities for the development of new therapeutic agents and synthetic methodologies. Continued research and interdisciplinary collaboration will be crucial in unlocking its full potential and translating laboratory findings into clinical applications.

• 83-72-7(Lawsone)
• 57960-31-3(acequinocyl-hydroxy)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)